(Q48949784)

17 February 2018

title

Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy. (English)

1 reference

17 February 2018

author name string

Fanchin R

1

1 reference

17 February 2018

Righini C

2

1 reference

17 February 2018

Olivennes F

3

1 reference

17 February 2018

Ferreira AL

4

1 reference

17 February 2018

de Ziegler D

5

1 reference

17 February 2018

Frydman R

6

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 November 1997

1 reference

17 February 2018

published in

Fertility and Sterility

1 reference

17 February 2018

volume

68

1 reference

17 February 2018

issue

5

1 reference

17 February 2018

page(s)

799-805

1 reference

17 February 2018

Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a "long protocol" of gonadotropin releasing hormone analogue and human menopausal gonadotropins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Physiopathology of premature progesterone elevation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Pregnancy rates in donors versus recipients according to the serum progesterone level at the time of human chorionic gonadotropin in a shared oocyte program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Elevated serum progesterone levels on the day of human chorionic gonadotropin administration in in vitro fertilization cycles do not adversely affect embryo quality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Premature progesterone elevation does not alter oocyte quality in in vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

The effect of progesterone administration in the follicular phase of an artificial cycle on endometrial morphology: a model of premature luteinization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Hormonal control of endometrial receptivity. The egg donation model and controlled ovarian hyperstimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Premature plasma progesterone and androgen elevation are not prevented by adrenal suppression in in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Current studies on human implantation: a brief overview.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

Role of embryonic factors in human implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900337-3

10.1016/S0015-0282(97)00337-3

7 January 2021

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018